RNA-Seq – News and Features

Genedata has developed a computational system to analyze molecular processes in mammalian liver cells.

Company will provide research informatics for the consortium’s efforts to improve cancer diagnosis and treatment.

Research involves sequencing, genome-wide functional studies and strain and process design.

Researchers are using Applied Biosystems’ MS Systems to systematically analyse the proteomes of normal and malignant stem cells.

SpliceArray products are now available on both Agilent and Affymetrix microarray platforms.

Almac licenses the Rosetta Resolver® system for use in the development of microarray-based approaches for diagnosing cancer.

The system combines the capability of managing the complex data arising from conventional proteomic studies.

The information garnered through metabolomics will lead to the development of diagnostic tools.

Genedata’s computational solution for drug discovery used to scale-up gene expression data analysis capabilities.

Genomatix is committed to integrating its entire microarray analysis pipeline with the Affymetrix technology.